Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hofmann

Showing results (481-490 of 603) with videos related to

Pageof 61
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 21, 2014
Hantavirus disease in Germany due to infection with Dobrava-Belgrade virus genotype KurkinoJ Hofmann, M Meier, M Enders, et al.
Biochemical Pharmacology|March 1, 1995
Mechanism of action of dexniguldipine-HCl (B8509-035), a new potent modulator of multidrug resistanceJ Hofmann, V Gekeler, W Ise, et al.
Brain and Language|May 8, 2015
Variability in lateralised blood flow response to language is associated with language development in children aged 1-5 yearsM Kohler, H A D Keage, R Spooner, et al.
Chembiochem : a European Journal of Chemical Biology|October 24, 2024
Ferrocenyl β-Diketonate Compounds: Extended Ring Systems for Improved Anticancer ActivityBenjamin J Hofmann, Enas T Aljohani, Natalia Cicovacki, et al.
Cureus|February 15, 2019
The Impact of Marijuana Legalization on Vehicular TraumaNatash Keric, Luke J Hofmann, Rachelle Babbitt-Jonas, et al.
Organometallics|August 18, 2023
Cytotoxicity of Ruthenium(II) Arene Complexes Containing Functionalized Ferrocenyl β-Diketonate LigandsMatthew Allison, Pablo Caramés-Méndez, Benjamin J Hofmann, et al.
Hepatology (Baltimore, Md.)|September 1, 1993
The humoral immune response to p53 in patients with hepatocellular carcinoma is specific for malignancy and independent of the alpha-fetoprotein statusM Volkmann, M Müller, W J Hofmann, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Effect of intraperitoneal recombinant human tumour necrosis factor alpha on malignant ascitesU Räth, M Kaufmann, H Schmid, et al.
British Journal of Cancer|May 18, 2001
MDR1 causes resistance to the antitumour drug miltefosineM Rybczynska, R Liu, P Lu, et al.
European Journal of Gastroenterology & Hepatology|August 19, 2003
Serum hyaluronate correlates with histological progression in alcoholic liver diseaseFelix Stickel, Gudrun Poeschl, Detlef Schuppan, et al.
Pageof 61

Showing results (481-490 of 603) with videos related to

Sort By:
Pageof 61
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 21, 2014
Hantavirus disease in Germany due to infection with Dobrava-Belgrade virus genotype KurkinoJ Hofmann, M Meier, M Enders, et al.
Biochemical Pharmacology|March 1, 1995
Mechanism of action of dexniguldipine-HCl (B8509-035), a new potent modulator of multidrug resistanceJ Hofmann, V Gekeler, W Ise, et al.
Brain and Language|May 8, 2015
Variability in lateralised blood flow response to language is associated with language development in children aged 1-5 yearsM Kohler, H A D Keage, R Spooner, et al.
Chembiochem : a European Journal of Chemical Biology|October 24, 2024
Ferrocenyl β-Diketonate Compounds: Extended Ring Systems for Improved Anticancer ActivityBenjamin J Hofmann, Enas T Aljohani, Natalia Cicovacki, et al.
Cureus|February 15, 2019
The Impact of Marijuana Legalization on Vehicular TraumaNatash Keric, Luke J Hofmann, Rachelle Babbitt-Jonas, et al.
Organometallics|August 18, 2023
Cytotoxicity of Ruthenium(II) Arene Complexes Containing Functionalized Ferrocenyl β-Diketonate LigandsMatthew Allison, Pablo Caramés-Méndez, Benjamin J Hofmann, et al.
Hepatology (Baltimore, Md.)|September 1, 1993
The humoral immune response to p53 in patients with hepatocellular carcinoma is specific for malignancy and independent of the alpha-fetoprotein statusM Volkmann, M Müller, W J Hofmann, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Effect of intraperitoneal recombinant human tumour necrosis factor alpha on malignant ascitesU Räth, M Kaufmann, H Schmid, et al.
British Journal of Cancer|May 18, 2001
MDR1 causes resistance to the antitumour drug miltefosineM Rybczynska, R Liu, P Lu, et al.
European Journal of Gastroenterology & Hepatology|August 19, 2003
Serum hyaluronate correlates with histological progression in alcoholic liver diseaseFelix Stickel, Gudrun Poeschl, Detlef Schuppan, et al.
Pageof 61